Evaluation of the safety of piperacillin-tazobactam extended infusion in pediatric cystic fibrosis patients. Riggsbee D, Engdahl S, Pettit RS. Pediatr Pulmonol 2023;58:1092-1099.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Riggsbee D, Engdahl S, Pettit RS. Evaluation of the safety of piperacillin-tazobactam extended infusion in pediatric cystic fibrosis patients. Pediatr Pulmonol 2023;58:1092-1099.
PMID: 36593628